Literature DB >> 16274497

Matrix models for childhood infections: a Bayesian approach with applications to rubella and mumps.

M N Kanaan1, C P Farrington.   

Abstract

Mathematical modelling is an established tool for planning and monitoring vaccination programmes. However, the matrices describing contact rates are based on subjective choices, which have a large impact on results. This paper reviews published models and obtains prior model probabilities based on publication frequency and expert opinion. Using serological survey data on rubella and mumps, Bayesian methods of model choice are applied to select the most plausible models. Estimates of the basic reproduction number R0 are derived, taking into account model uncertainty and individual heterogeneity in contact rates. Twenty-two models are documented, for which publication frequency and expert opinion are negatively correlated. Using the expert prior with individual heterogeneity, R0=6.1 [95% credible region (CR) 4.3-9.2] for rubella and R0=19.3 (95% CR 4.0-31.5) for mumps. The posterior modes are insensitive to the prior for rubella but not for mumps. Overall, assortative models with individual heterogeneity are recommended.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16274497      PMCID: PMC2870334          DOI: 10.1017/S0950268805004528

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  12 in total

1.  Modelling vaccination programmes against measles in Taiwan.

Authors:  S C Chen; C F Chang; L J Jou; C M Liao
Journal:  Epidemiol Infect       Date:  2006-10-26       Impact factor: 2.451

2.  Modelling the initial phase of an epidemic using incidence and infection network data: 2009 H1N1 pandemic in Israel as a case study.

Authors:  G Katriel; R Yaari; A Huppert; U Roll; L Stone
Journal:  J R Soc Interface       Date:  2011-01-19       Impact factor: 4.118

3.  Episodic outbreaks bias estimates of age-specific force of infection: a corrected method using measles as an example.

Authors:  M J Ferrari; A Djibo; R F Grais; B T Grenfell; O N Bjørnstad
Journal:  Epidemiol Infect       Date:  2009-06-19       Impact factor: 2.451

4.  Stage-structured transmission of phocine distemper virus in the Dutch 2002 outbreak.

Authors:  Petra Klepac; Laura W Pomeroy; Ottar N Bjørnstad; Thijs Kuiken; Albert D M E Osterhaus; Jolianne M Rijks
Journal:  Proc Biol Sci       Date:  2009-04-08       Impact factor: 5.349

5.  Social contacts of school children and the transmission of respiratory-spread pathogens.

Authors:  R T Mikolajczyk; M K Akmatov; S Rastin; M Kretzschmar
Journal:  Epidemiol Infect       Date:  2007-07-18       Impact factor: 2.451

6.  Representative contact diaries for modeling the spread of infectious diseases in Taiwan.

Authors:  Yang-chih Fu; Da-Wei Wang; Jen-Hsiang Chuang
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

7.  Estimation of vaccine efficacy and critical vaccination coverage in partially observed outbreaks.

Authors:  Michiel van Boven; Wilhelmina L M Ruijs; Jacco Wallinga; Philip D O'Neill; Susan Hahné
Journal:  PLoS Comput Biol       Date:  2013-05-02       Impact factor: 4.475

8.  Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study.

Authors:  Marc Baguelin; Stefan Flasche; Anton Camacho; Nikolaos Demiris; Elizabeth Miller; W John Edmunds
Journal:  PLoS Med       Date:  2013-10-08       Impact factor: 11.069

9.  Assessing the burden of congenital rubella syndrome in China and evaluating mitigation strategies: a metapopulation modelling study.

Authors:  Qiru Su; Zhilan Feng; Lixin Hao; Chao Ma; José E Hagan; Gavin B Grant; Ning Wen; Chunxiang Fan; Hong Yang; Lance E Rodewald; Huaqing Wang; John W Glasser
Journal:  Lancet Infect Dis       Date:  2021-01-27       Impact factor: 71.421

10.  Contact profiles in eight European countries and implications for modelling the spread of airborne infectious diseases.

Authors:  Mirjam Kretzschmar; Rafael T Mikolajczyk
Journal:  PLoS One       Date:  2009-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.